Next Article in Journal
Comparison of Liver Venous Deprivation Versus Portal Vein Embolization in Patients with Liver Malignancies: A Systematic Review
Previous Article in Journal
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach
Previous Article in Special Issue
Cutaneous Manifestations of Liver Cirrhosis: Clinical Significance and Diagnostic Implications
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Livers
Volume 5
Issue 3
10.3390/livers5030047
livers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Special Issue “Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment”

by
Ralf Weiskirchen
1,* and
Tilman Sauerbruch
2,*
1
Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany
2
Department of Internal Medicine I, University Hospital of Bonn, D-53127 Bonn, Germany
*
Authors to whom correspondence should be addressed.
Livers 2025, 5(3), 47; https://doi.org/10.3390/livers5030047
Submission received: 5 September 2025 / Accepted: 15 September 2025 / Published: 22 September 2025
(This article belongs to the Special Issue Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment)
Editorial Note: Due to an editorial processing error, this article was incorrectly excluded from the Special Issue Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment upon publication. This article was added to this Special Issue’s webpage on 26 September 2025, and will also remain within the regular issue in which it was originally published. The editorial office confirms that this article adhered to MDPI's Special Issue process and standard editorial process (https://www.mdpi.com/editorial_process).
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Liver fibrosis is a significant challenge in hepatology, as it represents the common pathway of chronic liver injury due to various causes such as viral hepatitis, metabolic dysfunction-associated steatotic liver disease (MASLD), intoxication, alcohol-related liver disease, autoimmune conditions, and genetic disorders [...]

Share and Cite

MDPI and ACS Style

Weiskirchen, R.; Sauerbruch, T. Special Issue “Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment”. Livers 2025, 5, 47. https://doi.org/10.3390/livers5030047

AMA Style

Weiskirchen R, Sauerbruch T. Special Issue “Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment”. Livers. 2025; 5(3):47. https://doi.org/10.3390/livers5030047

Chicago/Turabian Style

Weiskirchen, Ralf, and Tilman Sauerbruch. 2025. "Special Issue “Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment”" Livers 5, no. 3: 47. https://doi.org/10.3390/livers5030047

APA Style

Weiskirchen, R., & Sauerbruch, T. (2025). Special Issue “Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment”. Livers, 5(3), 47. https://doi.org/10.3390/livers5030047

Article Metrics

Back to TopTop